COMP <GO>
BCAX vs ZVRA // OPERATING MARGIN
Bicara Therapeutics Inc. (NASDAQ) VS. Zevra Therapeutics Inc. (NASDAQ) • 15-METRIC TALLY: BCAX 0
— ZVRA 5
■ METRIC PARITY
LAST: $7.93 (-13.14%) • MKT CAP: $604.2M
operating-margins
—
LAST: $10.10 (-1.75%) • MKT CAP: $610.5M
operating-margins
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (BCAX VS. ZVRA)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | BCAX | ZVRA | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | -32.30% | -2.70 | ZVRA | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -16.64% | -0.40% | -16.24 | ZVRA | /fcf-yield <GO> |
| Operating Margin ACTIVE | — | — | — | TIE | /operating-margins <GO> |
| Net Profit Margin | — | — | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | — | — | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 2/9 | 4/9 | -2.00 | ZVRA | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 20.5 | 45.8 | -25.30 | ZVRA | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | 6.9x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $604.2M | $610.5M | -$6.3M | ZVRA | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | BCAX REV | ZVRA REV | BCAX GROSS % | ZVRA GROSS % | BCAX FCF | ZVRA FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $435.7M | $176.2M | — | — | -$107.1M | -$2.4M |
| FY 2024 | $230.7M | $243.6M | — | — | -$74.8M | -$69.7M |
| FY 2023 | $111.7M | $138.9M | — | — | -$45.6M | -$33.5M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
BCAX // BETA —
ZVRA // BETA —